Semler Scientific CEO Option Exercise and Share Sale Disclosed
Rhea-AI Filing Summary
Semler Scientific insider activity: Dr. Douglas Murphy-Chutorian, Semler Scientific (SMLR) CEO and director, exercised options and completed related sales on 08/25/2025. He exercised a stock option with a $2.56 exercise price to acquire 60,000 shares; those underlying options were fully vested and immediately exercisable. To cover the exercise cost and withholding taxes he sold 28,604 shares at a weighted average price of $30.54 per share (sales executed between $30.33 and $30.92). He transferred beneficial ownership of 31,396 shares into a family trust (co-trustee with spouse) and reports indirect beneficial ownership of 186,709 shares following the transactions.
Positive
- Acquisition of 60,000 shares via exercise at a low $2.56 strike converts incentives into long-term equity alignment.
Negative
- Sale of 28,604 shares at a weighted average of $30.54, though disclosed as to cover exercise and taxes, reduces direct share holdings.
Insights
TL;DR: CEO exercised vested options, sold a portion to cover costs, and increased reported indirect holdings via a family trust.
The exercise of 60,000 options at $2.56 is a routine executive equity realization that converts incentive compensation into common stock. The sale of 28,604 shares at a weighted average of $30.54 appears limited and is explained as covering the exercise price and withholding taxes, reducing direct holdings while increasing reported indirect holdings via trust transfers. For investors, this is a typical liquidity-related transaction rather than a signal of company-specific distress or major portfolio reallocation.
TL;DR: Transaction follows standard governance and disclosure practices; trust transfer creates indirect holdings with shared voting power.
The filing discloses that Dr. Murphy-Chutorian and his spouse are co-trustees of a family trust that now holds 31,396 shares, producing indirect beneficial ownership of 186,709 shares. The Form 4 includes required explanations and price ranges for sales, and confirms the options were fully vested and immediately exercisable. From a governance perspective, the transfer to a family trust with shared voting and investment power should be monitored for any future coordinated voting with other insiders but is a common estate and tax planning step.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 60,000 | $0.00 | -- |
| Exercise | Common Stock | 60,000 | $2.56 | $154K |
| Sale | Common Stock | 28,604 | $30.54 | $874K |
| Gift | Common Stock | 31,396 | $0.00 | -- |
| Gift | Common Stock | 31,396 | $0.00 | -- |
Footnotes (1)
- The shares were sold by the reporting person to cover the exercise price and withholding taxes. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.33 to $30.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Shares are held in a family trust over which Dr. Murphy-Chutorian is co-Trustee with his spouse, and with whom he shares voting and investment power over such securities. The shares underlying the option are fully vested and immediately exercisable.
